GeneDx Holdings WGS
NASDAQ WGS
$89.17 -1.12 (-1.23%)
As of: Aug 27, 2026 · 3:59 PM EDT

GeneDx Holdings (WGS) Long-Term Investments (2020 - 2021)

GeneDx Holdings (WGS) posted quarterly Long-Term Investments of $442.8 million for Q2 2021, little changed quarter-over-quarter from $442.8 million in Q1 2021.

GeneDx Holdings (WGS) Long-Term Investments (2020 - 2021) Analysis & Trends

GeneDx Holdings (WGS) has reported Long-Term Investments for 2 consecutive years, with $442.8 million the latest figure, recorded in Q2 2021.

  • In Q2 2021, Long-Term Investments changed N/A year-over-year to $442.8 million; the TTM figure through Jun 2021 stood at $442.8 million (changed N/A YoY), while the FY2020 annual figure was $442.8 million, changed N/A from the prior year.
  • Long-Term Investments steadied at $442.8 million in Q2 2021 per WGS's latest filing, from $442.8 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $442.8 million in Q2 2021 and bottomed at $442.8 million in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn -
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 136.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn 390.00 Mn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn -
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn -
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 210.00 Mn
10 GeneDx Holdings 2.65 Bn 2.52 Bn 78.24 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 442.79 Mn
Mar 31, 2021 442.77 Mn
Dec 31, 2020 442.76 Mn
Sep 30, 2020 442.75 Mn